Tom C. Thomas - 15 Nov 2022 Form 4 Insider Report for Vincerx Pharma, Inc. (VINC)

Role: Officer
Signature: By: /s/ Tom C. Thomas
Issuer symbol: VINC
Transactions as of: 15 Nov 2022
Net transactions value: $0
Form type: 4
Filing time: 17 Nov 2022, 15:06:34 UTC
Previous filing: 29 Aug 2022
Next filing: 14 Dec 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VINC	Stock Option (right to buy)	Award	$0	+56,000		$0.000000	56,000	15 Nov 2022	Common Stock	56,000	$0.8170	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Option vests in twenty-four equal monthly installments starting from November 15, 2022.

Remarks:

General Counsel and Chief Legal Officer Represents the 2nd tranche of stock option grants previously approved by the Compensation Committee on August 25, 2022.